GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 793 filers reported holding GLAXOSMITHKLINE PLC in Q2 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $1,599,000 | -1.2% | 36,700 | 0.0% | 0.70% | +0.4% |
Q4 2021 | $1,618,000 | +15.4% | 36,700 | 0.0% | 0.70% | +9.9% |
Q3 2021 | $1,402,000 | -4.0% | 36,700 | 0.0% | 0.64% | -5.2% |
Q2 2021 | $1,461,000 | +11.5% | 36,700 | 0.0% | 0.67% | +3.7% |
Q1 2021 | $1,310,000 | -3.0% | 36,700 | 0.0% | 0.65% | -6.6% |
Q4 2020 | $1,351,000 | -2.2% | 36,700 | 0.0% | 0.70% | -14.8% |
Q3 2020 | $1,381,000 | -7.7% | 36,700 | 0.0% | 0.82% | -11.6% |
Q2 2020 | $1,497,000 | +7.6% | 36,700 | 0.0% | 0.92% | -15.4% |
Q1 2020 | $1,391,000 | -19.4% | 36,700 | 0.0% | 1.09% | +4.0% |
Q4 2019 | $1,725,000 | +10.2% | 36,700 | 0.0% | 1.05% | +11.2% |
Q3 2019 | $1,566,000 | +6.6% | 36,700 | 0.0% | 0.94% | +20.0% |
Q2 2019 | $1,469,000 | -4.2% | 36,700 | 0.0% | 0.79% | -5.0% |
Q1 2019 | $1,534,000 | +9.4% | 36,700 | 0.0% | 0.83% | -2.8% |
Q4 2018 | $1,402,000 | -4.9% | 36,700 | 0.0% | 0.85% | +10.8% |
Q3 2018 | $1,474,000 | -0.3% | 36,700 | 0.0% | 0.77% | -12.7% |
Q2 2018 | $1,479,000 | – | 36,700 | – | 0.88% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |